ANNEXIN PHARM. AB (PUBL)

Share · SE0009664154 · A2DX74 (XSTO)

Overview

No Price

Closing Price XSTO 30.01.2026: 14,70 SEK

30.01.2026 16:19

Current Prices from ANNEXIN PHARM. AB (PUBL)

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	ANNX.ST	SEK	30.01.2026 16:19	14,70 SEK	0,40 SEK +2,80 %

Share Float & Liquidity

Free Float 50,41 %

Shares Float 3,56 M

Shares Outstanding 7,06 M

Company Profile for ANNEXIN PHARM. AB (PUBL) Share

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.

AI Analysis of ANNEXIN PHARM. AB (PUBL)

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of ANNEXIN PHARM. AB (PUBL)

No AI threads available for this company yet.

Company Data

Name ANNEXIN PHARM. AB (PUBL)

Company Annexin Pharmaceuticals AB (publ)

Website https://www.annexinpharma.com/sv

Primary Exchange

Frankfurt

WKN A2DX74

ISIN SE0009664154

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Anders Haegerstrand

Market Capitalization 179 Mio

Country Sweden

Currency EUR

Employees 0,0 T

Address Drottninggatan 65, 111 36 Stockholm

IPO Date 2017-04-19

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	ANNX.ST
Frankfurt	Q91.F

More Shares

Investors who hold ANNEXIN PHARM. AB (PUBL) also have the following shares in their portfolio:

AMER.HONDA F. 18/28 MTN Bond

Lux Real Estate Investments SA DL-Notes 2024(39) Series 2 Unbekannt

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog